![Ian Pitfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Pitfield
Teknisk/Vetenskaplig/F&U Direktör på
GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profil
Ian Pitfield is a professional who has worked as the Head of Cell & Gene Therapy Medicine at GSK Plc from 1993 to 2016.
Currently, he is the Senior Vice President-Technical Operations at Gyroscope Therapeutics Holdings Plc since 2020.
Dr. Pitfield holds a doctorate degree from the University of Cambridge.
Aktiva positioner av Ian Pitfield
| Företag | Position | Start |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Teknisk/Vetenskaplig/F&U Direktör | 2020-07-01 |
Tidigare kända positioner av Ian Pitfield
| Företag | Position | Slut |
|---|---|---|
| GSK PLC | Företagsledare/Principal | 2016-12-01 |
Ian Pitfields utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
93
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
